23andMe to Sell Genetic Tests for Disease Risk to Consumers
Felicia Rodriguez
April 19, 2017
It has just been announced that 23andMe has been granted permission by the FDA to sell genetic tests for disease risk directly to the public. This very interesting development touches upon the potential growth that the biotech industry can achieve in the future. Other companies